Yuichi Sugiyama

Characterization of 5'-flanking region of human MRP3.

Y. Sugiyama, H. Suzuki, T. Takada, 2000, Biochemical and biophysical research communications.

Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data.

T Ishizaki, K Chiba, Y. Sugiyama, 1997, Pharmacology & therapeutics.

Positron Emission Tomography Studies Using (15R)-16-m-[11C]tolyl-17,18,19,20-tetranorisocarbacyclin Methyl Ester for the Evaluation of Hepatobiliary Transport

K. Maeda, H. Kusuhara, H. Doi, 2010, Journal of Pharmacology and Experimental Therapeutics.

Identification of the Hepatic Efflux Transporters of Organic Anions Using Double-Transfected Madin-Darby Canine Kidney II Cells Expressing Human Organic Anion-Transporting Polypeptide 1B1 (OATP1B1)/Multidrug Resistance-Associated Protein 2, OATP1B1/Multidrug Resistance 1, and OATP1B1/Breast Cancer R

K. Maeda, M. Hirano, Soichiro Matsushima, 2005, Journal of Pharmacology and Experimental Therapeutics.

Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor.

Y. Sugiyama, T. Nomura, A. Nomoto, 1997, Virology.

In vivo evidence for carrier-mediated efflux transport of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine across the blood-brain barrier via a probenecid-sensitive transport system.

Y. Sugiyama, T. Terasaki, H. Suzuki, 1997, The Journal of pharmacology and experimental therapeutics.

Transepithelial transport of organic anions across the choroid plexus: possible involvement of organic anion transporter and multidrug resistance-associated protein.

Y. Sugiyama, H. Suzuki, M. Hanano, 1999, The Journal of pharmacology and experimental therapeutics.

Reduced folate derivatives are endogenous substrates for cMOAT in rats.

H. Kusuhara, Y. Sugiyama, Y. H. Han, 1998, The American journal of physiology.